Global Amyotrophic Lateral Sclerosis Drugs Market Size, Status and Forecast 2024-2031

Report ID: 1013328 | Published Date: Jan 2025 | No. of Page: 109 | Base Year: 2024 | Rating: 4.7 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Riluzole
        1.2.3 Edaravone (Radicava)
        1.2.4 CoQ10
        1.2.5 Butylphthalide
        1.2.6 Others
    1.3 Market by Application
        1.3.1 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospital Pharmacies
        1.3.3 Retail Pharmacies
        1.3.4 Online Pharmacies
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Amyotrophic Lateral Sclerosis Drugs Market Perspective (2016-2027)
    2.2 Amyotrophic Lateral Sclerosis Drugs Growth Trends by Regions
        2.2.1 Amyotrophic Lateral Sclerosis Drugs Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Amyotrophic Lateral Sclerosis Drugs Historic Market Share by Regions (2016-2021)
        2.2.3 Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2022-2027)
    2.3 Amyotrophic Lateral Sclerosis Drugs Industry Dynamic
        2.3.1 Amyotrophic Lateral Sclerosis Drugs Market Trends
        2.3.2 Amyotrophic Lateral Sclerosis Drugs Market Drivers
        2.3.3 Amyotrophic Lateral Sclerosis Drugs Market Challenges
        2.3.4 Amyotrophic Lateral Sclerosis Drugs Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue
        3.1.1 Global Top Amyotrophic Lateral Sclerosis Drugs Players by Revenue (2016-2021)
        3.1.2 Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Players (2016-2021)
    3.2 Global Amyotrophic Lateral Sclerosis Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Amyotrophic Lateral Sclerosis Drugs Revenue
    3.4 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio
        3.4.1 Global Amyotrophic Lateral Sclerosis Drugs Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Amyotrophic Lateral Sclerosis Drugs Revenue in 2020
    3.5 Amyotrophic Lateral Sclerosis Drugs Key Players Head office and Area Served
    3.6 Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
    3.7 Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Type
    4.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Type (2016-2021)
    4.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2022-2027)

5 Amyotrophic Lateral Sclerosis Drugs Breakdown Data by Application
    5.1 Global Amyotrophic Lateral Sclerosis Drugs Historic Market Size by Application (2016-2021)
    5.2 Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
    6.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type
        6.2.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
        6.2.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
        6.2.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
    6.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application
        6.3.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
        6.3.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
        6.3.3 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
    6.4 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country
        6.4.1 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
        6.4.2 North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
    7.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type
        7.2.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
        7.2.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
        7.2.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
    7.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application
        7.3.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
        7.3.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
        7.3.3 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
    7.4 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country
        7.4.1 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
        7.4.2 Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
    8.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type
        8.2.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
    8.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application
        8.3.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
    8.4 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region
        8.4.1 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
    9.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type
        9.2.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
        9.2.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
        9.2.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
    9.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application
        9.3.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
        9.3.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
        9.3.3 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
    9.4 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country
        9.4.1 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
        9.4.2 Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size (2016-2027)
    10.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type
        10.2.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2027)
    10.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application
        10.3.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2027)
    10.4 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country
        10.4.1 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Sanofi
        11.1.1 Sanofi Company Details
        11.1.2 Sanofi Business Overview
        11.1.3 Sanofi Amyotrophic Lateral Sclerosis Drugs Introduction
        11.1.4 Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.1.5 Sanofi Recent Development
    11.2 Mitsubishi Tanabe Pharma
        11.2.1 Mitsubishi Tanabe Pharma Company Details
        11.2.2 Mitsubishi Tanabe Pharma Business Overview
        11.2.3 Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
        11.2.4 Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.2.5 Mitsubishi Tanabe Pharma Recent Development
    11.3 Mylan
        11.3.1 Mylan Company Details
        11.3.2 Mylan Business Overview
        11.3.3 Mylan Amyotrophic Lateral Sclerosis Drugs Introduction
        11.3.4 Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.3.5 Mylan Recent Development
    11.4 Apotex
        11.4.1 Apotex Company Details
        11.4.2 Apotex Business Overview
        11.4.3 Apotex Amyotrophic Lateral Sclerosis Drugs Introduction
        11.4.4 Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.4.5 Apotex Recent Development
    11.5 Glemark Generics
        11.5.1 Glemark Generics Company Details
        11.5.2 Glemark Generics Business Overview
        11.5.3 Glemark Generics Amyotrophic Lateral Sclerosis Drugs Introduction
        11.5.4 Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.5.5 Glemark Generics Recent Development
    11.6 Sun Pharma
        11.6.1 Sun Pharma Company Details
        11.6.2 Sun Pharma Business Overview
        11.6.3 Sun Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
        11.6.4 Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.6.5 Sun Pharma Recent Development
    11.7 Covis Pharma
        11.7.1 Covis Pharma Company Details
        11.7.2 Covis Pharma Business Overview
        11.7.3 Covis Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
        11.7.4 Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.7.5 Covis Pharma Recent Development
    11.8 Lunan Pharma
        11.8.1 Lunan Pharma Company Details
        11.8.2 Lunan Pharma Business Overview
        11.8.3 Lunan Pharma Amyotrophic Lateral Sclerosis Drugs Introduction
        11.8.4 Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.8.5 Lunan Pharma Recent Development
    11.9 CSPC Pharmaceutical
        11.9.1 CSPC Pharmaceutical Company Details
        11.9.2 CSPC Pharmaceutical Business Overview
        11.9.3 CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Introduction
        11.9.4 CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.9.5 CSPC Pharmaceutical Recent Development
    11.10 Ascend Laboratories
        11.10.1 Ascend Laboratories Company Details
        11.10.2 Ascend Laboratories Business Overview
        11.10.3 Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Introduction
        11.10.4 Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.10.5 Ascend Laboratories Recent Development
    11.11 EISAI
        11.11.1 EISAI Company Details
        11.11.2 EISAI Business Overview
        11.11.3 EISAI Amyotrophic Lateral Sclerosis Drugs Introduction
        11.11.4 EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
        11.11.5 EISAI Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Riluzole
    Table 3. Key Players of Edaravone (Radicava)
    Table 4. Key Players of CoQ10
    Table 5. Key Players of Butylphthalide
    Table 6. Key Players of Others
    Table 7. Global Amyotrophic Lateral Sclerosis Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 9. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Regions (2016-2021) & (US$ Million)
    Table 10. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2016-2021)
    Table 11. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 12. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2022-2027)
    Table 13. Amyotrophic Lateral Sclerosis Drugs Market Trends
    Table 14. Amyotrophic Lateral Sclerosis Drugs Market Drivers
    Table 15. Amyotrophic Lateral Sclerosis Drugs Market Challenges
    Table 16. Amyotrophic Lateral Sclerosis Drugs Market Restraints
    Table 17. Global Amyotrophic Lateral Sclerosis Drugs Revenue by Players (2016-2021) & (US$ Million)
    Table 18. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players (2016-2021)
    Table 19. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2020)
    Table 20. Ranking of Global Top Amyotrophic Lateral Sclerosis Drugs Companies by Revenue (US$ Million) in 2020
    Table 21. Global 5 Largest Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue (CR5 and HHI) & (2016-2021)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Amyotrophic Lateral Sclerosis Drugs Product Solution and Service
    Table 24. Date of Enter into Amyotrophic Lateral Sclerosis Drugs Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 27. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2016-2021)
    Table 28. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 29. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 30. Global Amyotrophic Lateral Sclerosis Drugs Market Size Share by Application (2016-2021) & (US$ Million)
    Table 31. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2016-2021)
    Table 32. Global Amyotrophic Lateral Sclerosis Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 33. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 34. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 35. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 36. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 37. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 38. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 39. North America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 40. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 41. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 42. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 43. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 44. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 45. Europe Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 46. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 49. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 50. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2016-2021) & (US$ Million) 
    Table 51. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size by Region (2022-2027) & (US$ Million) 
    Table 52. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 53. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 54. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 55. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 56. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 57. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 58. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Type (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2016-2021) (US$ Million)
    Table 61. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Application (2022-2027) & (US$ Million)
    Table 62. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2016-2021) & (US$ Million) 
    Table 63. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size by Country (2022-2027) & (US$ Million) 
    Table 64. Sanofi Company Details
    Table 65. Sanofi Business Overview
    Table 66. Sanofi Amyotrophic Lateral Sclerosis Drugs Product
    Table 67. Sanofi Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 68. Sanofi Recent Development
    Table 69. Mitsubishi Tanabe Pharma Company Details
    Table 70. Mitsubishi Tanabe Pharma Business Overview
    Table 71. Mitsubishi Tanabe Pharma Amyotrophic Lateral Sclerosis Drugs Product
    Table 72. Mitsubishi Tanabe Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 73. Mitsubishi Tanabe Pharma Recent Development
    Table 74. Mylan Company Details
    Table 75. Mylan Business Overview
    Table 76. Mylan Amyotrophic Lateral Sclerosis Drugs Product
    Table 77. Mylan Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 78. Mylan Recent Development
    Table 79. Apotex Company Details
    Table 80. Apotex Business Overview
    Table 81. Apotex Amyotrophic Lateral Sclerosis Drugs Product
    Table 82. Apotex Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 83. Apotex Recent Development
    Table 84. Glemark Generics Company Details
    Table 85. Glemark Generics Business Overview
    Table 86. Glemark Generics Amyotrophic Lateral Sclerosis Drugs Product
    Table 87. Glemark Generics Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 88. Glemark Generics Recent Development
    Table 89. Sun Pharma Company Details
    Table 90. Sun Pharma Business Overview
    Table 91. Sun Pharma Amyotrophic Lateral Sclerosis Drugs Product
    Table 92. Sun Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 93. Sun Pharma Recent Development
    Table 94. Covis Pharma Company Details
    Table 95. Covis Pharma Business Overview
    Table 96. Covis Pharma Amyotrophic Lateral Sclerosis Drugs Product
    Table 97. Covis Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 98. Covis Pharma Recent Development
    Table 99. Lunan Pharma Company Details
    Table 100. Lunan Pharma Business Overview
    Table 101. Lunan Pharma Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 102. Lunan Pharma Recent Development
    Table 103. CSPC Pharmaceutical Company Details
    Table 104. CSPC Pharmaceutical Business Overview
    Table 105. CSPC Pharmaceutical Amyotrophic Lateral Sclerosis Drugs Product
    Table 106. CSPC Pharmaceutical Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 107. CSPC Pharmaceutical Recent Development
    Table 108. Ascend Laboratories Company Details
    Table 109. Ascend Laboratories Business Overview
    Table 110. Ascend Laboratories Amyotrophic Lateral Sclerosis Drugs Product
    Table 111. Ascend Laboratories Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 112. Ascend Laboratories Recent Development
    Table 113. EISAI Company Details
    Table 114. EISAI Business Overview
    Table 115. EISAI Amyotrophic Lateral Sclerosis Drugs Product
    Table 116. EISAI Revenue in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021) & (US$ Million)
    Table 117. EISAI Recent Development
    Table 118. Research Programs/Design for This Report
    Table 119. Key Data Information from Secondary Sources
    Table 120. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Type: 2020 VS 2027
    Figure 2. Riluzole Features
    Figure 3. Edaravone (Radicava) Features
    Figure 4. CoQ10 Features
    Figure 5. Butylphthalide Features
    Figure 6. Others Features
    Figure 7. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Application: 2020 VS 2027
    Figure 8. Hospital Pharmacies Case Studies
    Figure 9. Retail Pharmacies Case Studies
    Figure 10. Online Pharmacies Case Studies
    Figure 11. Amyotrophic Lateral Sclerosis Drugs Report Years Considered
    Figure 12. Global Amyotrophic Lateral Sclerosis Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 13. Global Amyotrophic Lateral Sclerosis Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 14. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions: 2020 VS 2027
    Figure 15. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Regions (2022-2027)
    Figure 16. Global Amyotrophic Lateral Sclerosis Drugs Market Share by Players in 2020
    Figure 17. Global Top Amyotrophic Lateral Sclerosis Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Amyotrophic Lateral Sclerosis Drugs as of 2020
    Figure 18. The Top 10 and 5 Players Market Share by Amyotrophic Lateral Sclerosis Drugs Revenue in 2020
    Figure 19. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2016-2021)
    Figure 20. Global Amyotrophic Lateral Sclerosis Drugs Revenue Market Share by Type (2022-2027)
    Figure 21. North America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 22. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
    Figure 23. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
    Figure 24. North America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
    Figure 25. United States Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Canada Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 28. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
    Figure 29. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
    Figure 30. Europe Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
    Figure 31. Germany Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. France Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. U.K. Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Italy Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Russia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Nordic Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
    Figure 39. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
    Figure 40. Asia-Pacific Amyotrophic Lateral Sclerosis Drugs Market Share by Region (2016-2027)
    Figure 41. China Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Japan Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. South Korea Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Southeast Asia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. India Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Australia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
    Figure 49. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
    Figure 50. Latin America Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
    Figure 51. Mexico Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Brazil Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 54. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Type (2016-2027)
    Figure 55. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Application (2016-2027)
    Figure 56. Middle East & Africa Amyotrophic Lateral Sclerosis Drugs Market Share by Country (2016-2027)
    Figure 57. Turkey Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Saudi Arabia Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. UAE Amyotrophic Lateral Sclerosis Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 60. Sanofi Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 61. Mitsubishi Tanabe Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 62. Mylan Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 63. Apotex Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 64. Glemark Generics Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 65. Sun Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 66. Covis Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 67. Lunan Pharma Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 68. CSPC Pharmaceutical Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 69. Ascend Laboratories Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 70. EISAI Revenue Growth Rate in Amyotrophic Lateral Sclerosis Drugs Business (2016-2021)
    Figure 71. Bottom-up and Top-down Approaches for This Report
    Figure 72. Data Triangulation
    Figure 73. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Sanofi
Mitsubishi Tanabe Pharma
Mylan
Apotex
Glemark Generics
Sun Pharma
Covis Pharma
Lunan Pharma
CSPC Pharmaceutical
Ascend Laboratories
EISAI
Frequently Asked Questions
Amyotrophic Lateral Sclerosis Drugs report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Amyotrophic Lateral Sclerosis Drugs report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Amyotrophic Lateral Sclerosis Drugs report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Tenecteplase Drugs

Tenecteplase drug is an enzyme derived through recombinant DNA technology from a human cell line. ... Read More

Krabbe Disease Drugs

Krabbe disease is an uncommon and typically deadly concern of the nervous system. It is an acquir ... Read More